Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation
4 affiliations
- 1Department of Pathology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands
- 2Institute of Frontier Medical Sciences, Jilin University, Changchun 130021, China
- 3Department of Clinical Genetics, Erasmus University Medical Center, Sophia Children’s Hospital, 3015 GD Rotterdam, The Netherlands
- 4State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China
Abstract
Cancer treatment increasingly relies on integrated therapeutic approaches, particularly for solid tumors that remain difficult to eradicate using a single modality. Magnetic nanoparticles (MNPs) have emerged as versatile therapeutic platforms owing to their magnetic responsiveness and tunable physicochemical properties. Advances in synthesis methods enable precise control over MNP size, morphology, composition, and surface chemistry, shaping their biological behavior across multiple scales. At the cellular level, these properties regulate nanoparticle uptake, intracellular trafficking, and subcellular interactions. At the tissue and systemic levels, administration route, vascular transport, magnetic targeting, and ligand-mediated recognition influence biodistribution, tumor accumulation, and cellular selectivity. Material composition and surface functionalization further determine responsiveness to external or endogenous stimuli and mediate therapeutic effects, including heat generation, controlled drug release, catalytic activity, and reactive oxygen species production. These features allow MNP-based systems to support localized hyperthermia, drug delivery, catalytic therapies, and embolization-based interventions, making them attractive for treating deep-seated and inoperable tumors. However, heterogeneous tumor delivery, variable activation efficiency, off-target toxicity, and long-term safety concerns remain major barriers to clinical translation. Overall, this review summarizes recent advances and current limitations in MNP-based cancer therapy, providing a multiscale perspective that links material design, biological interactions, systemic delivery, therapeutic activation, and translational challenges.
Related
- Navigating the Biomolecular Corona: Biological Interactions and Therapeutic Implications of RNA–Lipid Nanoparticles
- Mind the gap between functional groups and surface of magnetic nanoparticles for highly specific magnetic-based protein assays in biological medium
- Synthesis and biological activities of isogranulatimide analogues
- Exosomes in regenerative medicine from biological messengers to engineered nanocarriers for precision therapeutics
- Total Synthesis-Assisted Structure Determination and Biological Evaluation of Cytotoxic Cyclodepsipeptide Destruxin F
BibTeX
@article{wang2026magnetic,
title = {{Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation}},
author = {Jing Wang and Shizhi Xu and Seyedeh Maryam Hosseinikhah and Wei Zhang and Xiao Zhang and Andrea Sacchetti},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms27219938},
url = {https://www.mdpi.com/1422-0067/27/21/9938},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Magnetic Nanoparticles in Precision Cancer Therapy: From Synthesis and Biological Interactions to Clinical Translation
AU - Jing Wang
AU - Shizhi Xu
AU - Seyedeh Maryam Hosseinikhah
AU - Wei Zhang
AU - Xiao Zhang
AU - Andrea Sacchetti
PY - 2026
DA - 2026/11/06
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219938
UR - https://www.mdpi.com/1422-0067/27/21/9938
AB - Cancer treatment increasingly relies on integrated therapeutic approaches, particularly for solid tumors that remain difficult to eradicate using a single modality. Magnetic nanoparticles (MNPs) have emerged as versatile therapeutic platforms owing to their magnetic responsiveness and tunable physicochemical properties. Advances in synthesis methods enable precise control over MNP size, morphology, composition, and surface chemistry, shaping their biological behavior across multiple scales. At the cellular level, these properties regulate nanoparticle uptake, intracellular trafficking, and subcellular interactions. At the tissue and systemic levels, administration route, vascular transport, magnetic targeting, and ligand-mediated recognition influence biodistribution, tumor accumulation, and cellular selectivity. Material composition and surface functionalization further determine responsiveness to external or endogenous stimuli and mediate therapeutic effects, including heat generation, controlled drug release, catalytic activity, and reactive oxygen species production. These features allow MNP-based systems to support localized hyperthermia, drug delivery, catalytic therapies, and embolization-based interventions, making them attractive for treating deep-seated and inoperable tumors. However, heterogeneous tumor delivery, variable activation efficiency, off-target toxicity, and long-term safety concerns remain major barriers to clinical translation. Overall, this review summarizes recent advances and current limitations in MNP-based cancer therapy, providing a multiscale perspective that links material design, biological interactions, systemic delivery, therapeutic activation, and translational challenges.
SN - 1422-0067
ER -